(TER) Teradyne - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8807701029
Stock: Test Systems, Robotics, Instruments
Total Rating 84
Risk 80
Buy Signal 0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 66.0% |
| Relative Tail Risk | -12.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.29 |
| Alpha | 146.07 |
| Character TTM | |
|---|---|
| Beta | 2.148 |
| Beta Downside | 2.179 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.18% |
| CAGR/Max DD | 0.76 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 85.4294
Description: TER Teradyne March 05, 2026
Teradyne Inc. designs and manufactures automated test systems and robotics. The company operates globally, with significant presence in Asia Pacific and Europe. Its business model focuses on providing essential equipment for technology manufacturing and automation.
The Semiconductor Test segment provides products for testing semiconductor devices. This includes wafer-level, device package, and system-level testing across various applications such as automotive, consumer electronics, and cloud computing. This sector is cyclical, tied to semiconductor demand. Teradyne serves integrated device manufacturers, fabless companies, foundries, and outsourced assembly and test providers.
The Robotics segment offers collaborative robotic arms and autonomous mobile robots. These products are used in manufacturing, logistics, and industrial settings. The robotics market is experiencing growth due to increasing automation in various industries. This segment also includes specialized test instruments for defense/aerospace, circuit-board, wireless, and silicon photonics testing.
For more detailed financial analysis and competitive positioning, investors may wish to explore ValueRays comprehensive reports.
Headlines to watch out for
- Semiconductor test equipment demand drives revenue
- Robotics segment growth expands market share
- Global electronics production impacts test system sales
- Automotive and industrial sectors boost robotics orders
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 554.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.98 > 1.0 |
| NWC/Revenue: 26.15% < 20% (prev 42.26%; Δ -16.12% < -1%) |
| CFO/TA 0.16 > 3% & CFO 674.4m > Net Income 554.0m |
| Net Debt (53.4m) to EBITDA (780.1m): 0.07 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.7m) vs 12m ago -3.39% < -2% |
| Gross Margin: 58.32% > 18% (prev 0.58%; Δ 5.77k% > 0.5%) |
| Asset Turnover: 80.98% > 50% (prev 76.03%; Δ 4.94% > 0%) |
| Interest Coverage Ratio: 81.39 > 6 (EBITDA TTM 780.1m / Interest Expense TTM 8.02m) |
Altman Z'' 5.71
| A: 0.20 (Total Current Assets 1.94b - Total Current Liabilities 1.10b) / Total Assets 4.17b |
| B: 0.18 (Retained Earnings 744.4m / Total Assets 4.17b) |
| C: 0.17 (EBIT TTM 652.9m / Avg Total Assets 3.94b) |
| D: 2.58 (Book Value of Equity 3.54b / Total Liabilities 1.37b) |
| Altman-Z'' Score: 5.71 = AAA |
Beneish M -2.55
| DSRI: 1.45 (Receivables 773.6m/471.4m, Revenue 3.19b/2.82b) |
| GMI: 1.00 (GM 58.32% / 58.48%) |
| AQI: 1.07 (AQ_t 0.38 / AQ_t-1 0.35) |
| SGI: 1.13 (Revenue 3.19b / 2.82b) |
| TATA: -0.03 (NI 554.0m - CFO 674.4m) / TA 4.17b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of TER shares?
As of March 15, 2026, the stock is trading at USD 301.99 with a total of 2,578,605 shares traded.
Over the past week, the price has changed by +4.90%, over one month by -8.97%, over three months by +47.17% and over the past year by +236.91%.
Over the past week, the price has changed by +4.90%, over one month by -8.97%, over three months by +47.17% and over the past year by +236.91%.
Is TER a buy, sell or hold?
Teradyne has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy TER.
- StrongBuy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 307.4 | 1.8% |
| Analysts Target Price | 307.4 | 1.8% |
TER Fundamental Data Overview March 11, 2026
P/E Trailing = 85.4294
P/E Forward = 47.1698
P/S = 14.5483
P/B = 15.2902
P/EG = 1.5734
Revenue TTM = 3.19b USD
EBIT TTM = 652.9m USD
EBITDA TTM = 780.1m USD
Long Term Debt = 83.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 219.3m USD (from shortTermDebt, last quarter)
Debt = 347.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.4m USD (from netDebt column, last quarter)
Enterprise Value = 46.43b USD (46.41b + Debt 347.1m - CCE 322.0m)
Interest Coverage Ratio = 81.39 (Ebit TTM 652.9m / Interest Expense TTM 8.02m)
EV/FCF = 103.1x (Enterprise Value 46.43b / FCF TTM 450.4m)
FCF Yield = 0.97% (FCF TTM 450.4m / Enterprise Value 46.43b)
FCF Margin = 14.12% (FCF TTM 450.4m / Revenue TTM 3.19b)
Net Margin = 17.37% (Net Income TTM 554.0m / Revenue TTM 3.19b)
Gross Margin = 58.32% ((Revenue TTM 3.19b - Cost of Revenue TTM 1.33b) / Revenue TTM)
Gross Margin QoQ = 57.49% (prev 58.41%)
Tobins Q-Ratio = 11.13 (Enterprise Value 46.43b / Total Assets 4.17b)
Interest Expense / Debt = 1.04% (Interest Expense 3.62m / Debt 347.1m)
Taxrate = 10.18% (29.2m / 286.4m)
NOPAT = 586.4m (EBIT 652.9m * (1 - 10.18%))
Current Ratio = 1.76 (Total Current Assets 1.94b / Total Current Liabilities 1.10b)
Debt / Equity = 0.12 (Debt 347.1m / totalStockholderEquity, last quarter 2.80b)
Debt / EBITDA = 0.07 (Net Debt 53.4m / EBITDA 780.1m)
Debt / FCF = 0.12 (Net Debt 53.4m / FCF TTM 450.4m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.06% (Net Income 554.0m / Total Assets 4.17b)
RoE = 19.88% (Net Income TTM 554.0m / Total Stockholder Equity 2.79b)
RoCE = 22.75% (EBIT 652.9m / Capital Employed (Equity 2.79b + L.T.Debt 83.2m))
RoIC = 20.67% (NOPAT 586.4m / Invested Capital 2.84b)
WACC = 13.73% (E(46.41b)/V(46.76b) * Re(13.83%) + D(347.1m)/V(46.76b) * Rd(1.04%) * (1-Tc(0.10)))
Discount Rate = 13.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.38%
[DCF] Terminal Value 60.41% ; FCFF base≈459.9m ; Y1≈468.6m ; Y5≈515.2m
[DCF] Fair Price = 26.85 (EV 4.26b - Net Debt 53.4m = Equity 4.20b / Shares 156.6m; r=13.73% [WACC]; 5y FCF grow 1.70% → 2.90% )
EPS Correlation: -1.74 | EPS CAGR: 17.60% | SUE: 4.0 | # QB: 2
Revenue Correlation: 13.53 | Revenue CAGR: 10.09% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.92 | Chg7d=-0.012 | Chg30d=-0.011 | Revisions Net=+0 | Analysts=16
EPS current Year (2026-12-31): EPS=6.25 | Chg7d=-0.024 | Chg30d=+0.008 | Revisions Net=+13 | Growth EPS=+57.7% | Growth Revenue=+31.1%
EPS next Year (2027-12-31): EPS=8.11 | Chg7d=+0.081 | Chg30d=+0.097 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+19.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.7% (Discount Rate 13.8% - Earnings Yield 1.2%)
[Growth] Growth Spread = +66.7% (Analyst 79.4% - Implied 12.7%)
P/E Forward = 47.1698
P/S = 14.5483
P/B = 15.2902
P/EG = 1.5734
Revenue TTM = 3.19b USD
EBIT TTM = 652.9m USD
EBITDA TTM = 780.1m USD
Long Term Debt = 83.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 219.3m USD (from shortTermDebt, last quarter)
Debt = 347.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.4m USD (from netDebt column, last quarter)
Enterprise Value = 46.43b USD (46.41b + Debt 347.1m - CCE 322.0m)
Interest Coverage Ratio = 81.39 (Ebit TTM 652.9m / Interest Expense TTM 8.02m)
EV/FCF = 103.1x (Enterprise Value 46.43b / FCF TTM 450.4m)
FCF Yield = 0.97% (FCF TTM 450.4m / Enterprise Value 46.43b)
FCF Margin = 14.12% (FCF TTM 450.4m / Revenue TTM 3.19b)
Net Margin = 17.37% (Net Income TTM 554.0m / Revenue TTM 3.19b)
Gross Margin = 58.32% ((Revenue TTM 3.19b - Cost of Revenue TTM 1.33b) / Revenue TTM)
Gross Margin QoQ = 57.49% (prev 58.41%)
Tobins Q-Ratio = 11.13 (Enterprise Value 46.43b / Total Assets 4.17b)
Interest Expense / Debt = 1.04% (Interest Expense 3.62m / Debt 347.1m)
Taxrate = 10.18% (29.2m / 286.4m)
NOPAT = 586.4m (EBIT 652.9m * (1 - 10.18%))
Current Ratio = 1.76 (Total Current Assets 1.94b / Total Current Liabilities 1.10b)
Debt / Equity = 0.12 (Debt 347.1m / totalStockholderEquity, last quarter 2.80b)
Debt / EBITDA = 0.07 (Net Debt 53.4m / EBITDA 780.1m)
Debt / FCF = 0.12 (Net Debt 53.4m / FCF TTM 450.4m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.06% (Net Income 554.0m / Total Assets 4.17b)
RoE = 19.88% (Net Income TTM 554.0m / Total Stockholder Equity 2.79b)
RoCE = 22.75% (EBIT 652.9m / Capital Employed (Equity 2.79b + L.T.Debt 83.2m))
RoIC = 20.67% (NOPAT 586.4m / Invested Capital 2.84b)
WACC = 13.73% (E(46.41b)/V(46.76b) * Re(13.83%) + D(347.1m)/V(46.76b) * Rd(1.04%) * (1-Tc(0.10)))
Discount Rate = 13.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.38%
[DCF] Terminal Value 60.41% ; FCFF base≈459.9m ; Y1≈468.6m ; Y5≈515.2m
[DCF] Fair Price = 26.85 (EV 4.26b - Net Debt 53.4m = Equity 4.20b / Shares 156.6m; r=13.73% [WACC]; 5y FCF grow 1.70% → 2.90% )
EPS Correlation: -1.74 | EPS CAGR: 17.60% | SUE: 4.0 | # QB: 2
Revenue Correlation: 13.53 | Revenue CAGR: 10.09% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.92 | Chg7d=-0.012 | Chg30d=-0.011 | Revisions Net=+0 | Analysts=16
EPS current Year (2026-12-31): EPS=6.25 | Chg7d=-0.024 | Chg30d=+0.008 | Revisions Net=+13 | Growth EPS=+57.7% | Growth Revenue=+31.1%
EPS next Year (2027-12-31): EPS=8.11 | Chg7d=+0.081 | Chg30d=+0.097 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+19.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.7% (Discount Rate 13.8% - Earnings Yield 1.2%)
[Growth] Growth Spread = +66.7% (Analyst 79.4% - Implied 12.7%)